ICD-10 Code L80 – Vitiligo

Key Takeaways

ICD-10 Code L80 is the billable ICD-10-CM diagnosis code for vitiligo; nonspecific leukoderma without a confirmed vitiligo diagnosis is coded separately to L81.5

L80 has no Excludes1 restrictions, meaning it can be coded alongside other diagnoses without conflict in most clinical scenarios

Common coding error: using a non-specific pigmentation code when vitiligo has been clinically confirmed; L80 is the correct specific code

Practice management software like Pabau supports structured clinical notes and diagnosis code documentation to reduce L80 coding errors at the point of care

ICD-10 Code L80: Definition, Description, and Billable Status

Most vitiligo cases get miscoded. Coders reach for broader pigmentation disorder codes when a confirmed vitiligo diagnosis should go straight to ICD-10 Code L80. That choice costs practices clean claims and slows reimbursement. According to the CDC/NCHS ICD-10-CM web tool, L80 is a valid, specific, billable code with no ambiguity about its clinical scope.

This reference covers everything dermatologists, aesthetics practitioners, and medical coders need to use L80 correctly: its official description, includes and excludes annotations, related codes in the L80-L99 block, documentation requirements, and CPT pairings for common vitiligo treatment visits.

Clinical description of vitiligo

Vitiligo is a chronic, acquired autoimmune skin disorder. The immune system’s T-cells attack and destroy melanocytes, the pigment-producing cells in the skin, resulting in characteristic depigmented white patches.

The full-body skin mapping workflows used in dermatology practices are particularly relevant here, because vitiligo progresses unpredictably and documenting the extent and distribution of affected skin at each visit is essential for treatment planning and insurance justification.

Key clinical features

• Depigmented patches: white or milky patches on skin, mucous membranes, or hair
• Autoimmune mechanism: T-cell mediated destruction of melanocytes, confirmed by the American Academy of Dermatology (AAD) and NIH clinical guidelines
• Prevalence: affects approximately 0.5-2% of the global population, per WHO estimates
• Pattern types: segmental (one side, stable), non-segmental (bilateral, progressive), and universal vitiligo
• Associated conditions: thyroid disease, type 1 diabetes, and other autoimmune disorders are frequently comorbid
• Terminology: leukoderma is a descriptive term for depigmentation; it maps to L80 only when the presentation is clinically confirmed as vitiligo, otherwise it is coded separately to L81.5

For practices using skin assessment tools in their clinical workflows, vitiligo presentations benefit from structured photographic documentation at each visit to track treatment response and support insurance submissions coded under L80.

Leukoderma is a descriptive term for depigmentation, not a diagnosis in itself. When a leukoderma presentation is clinically confirmed as vitiligo, L80 is the correct code. When chart documentation states leukoderma NOS without a vitiligo diagnosis, the correct code is L81.5 (Leukoderma, not elsewhere classified), not L80.

L80 code details: Includes, excludes, and annotations

Understanding the includes and excludes structure for ICD-10 Code L80 prevents two of the most common coding errors: assigning L80 when a more specific code applies, and failing to code L80 when it is the most accurate option.

Because L80 carries no Excludes1 restrictions, it can be reported alongside comorbid diagnoses in the same encounter. A patient presenting with vitiligo and concurrent autoimmune thyroiditis, for example, can have both conditions coded without conflict.

ICD-10-CM code block L80-L99: Related pigmentation disorder codes

ICD-10 Code L80 sits within the L80-L99 block (Other disorders of skin and subcutaneous tissue, NEC). When a diagnosis does not clearly meet the criteria for vitiligo or leukoderma, the following adjacent codes in the block may apply. Selecting the most specific code is essential; the AAPC Codify ICD-10-CM lookup can help verify code descriptions against the current tabular list.

The same discipline applies to other ICD-10-CM codes with easily confused subcategories, such as ICD-10 code M72.8: always code to the highest level of specificity supported by chart documentation.

Billable Status and Version History for ICD-10 Code L80

ICD-10 Code L80 has been a valid, billable diagnosis code since the introduction of ICD-10-CM in the United States. The CMS ICD-10 codes page confirms L80 remains valid for FY2026 with no structural changes, deleted subcodes, or revised descriptions from the prior fiscal year.

This stability matters for practices running year-end billing audits. Unlike some dermatology codes that have seen expansions or deletions in recent ICD-10-CM annual updates, L80 has maintained a consistent, single-code structure since its adoption.

L80 represents one of the more stable entries in the L80-L99 block, reducing the risk of annual code invalidation for ongoing vitiligo cases. Other codes with similarly stable histories, like ICD-10 code R61, follow the same low-churn pattern year over year.

Documentation tips for vitiligo ICD-10 coding

Clean L80 claims start with complete clinical notes. Payers auditing dermatology claims specifically look for documentation that supports the diagnosis rather than a coder’s assumption. These steps apply whether you’re coding for an initial presentation or a follow-up visit for an established vitiligo patient.

Practices using structured digital intake forms at the point of care capture the documentation detail needed to support L80 coding before the note is ever written, reducing the need for provider queries after the encounter closes.

1. Document the diagnosis explicitly. The provider must state “vitiligo” in the assessment, or confirm that a leukoderma presentation is vitiligo. “Hypopigmentation,” “white patches,” or “leukoderma NOS” alone is insufficient for L80 coding; nonspecific leukoderma belongs under L81.5.
2. Note the distribution and extent. Specify whether patches are segmental or non-segmental, the body regions involved, and the estimated percentage of body surface affected. This supports treatment necessity for phototherapy claims.
3. Record associated autoimmune history. If the patient has comorbid thyroid disease or type 1 diabetes, code these separately. The absence of Excludes1 on L80 means comorbid autoimmune diagnoses can be submitted in the same encounter.
4. Confirm no drug-induced cause. When a patient is on medications known to cause depigmentation, verify the provider has ruled out drug-induced hypopigmentation before assigning L80. If drug-induced, apply the appropriate adverse effect code.
5. Photograph and document treatment response. For ongoing phototherapy or laser treatment visits, note the lesion response at each encounter. Payers use this documentation to justify continued treatment authorization.

Using skin assessment tools within your clinical documentation workflow ensures providers capture the distribution detail needed to defend L80 on audit. Structured SOAP notes with explicit vitiligo language are significantly less likely to trigger claim review than free-text notes with vague pigmentation descriptors.

The same principle holds for procedure codes billed alongside a chronic skin condition diagnosis, such as CPT code 11640: the code is only as defensible as the chart note behind it.

Reduce vitiligo coding errors with structured dermatology documentation

Pabau helps dermatology and skin care practice teams capture the clinical detail that makes L80 claims stick. Built-in digital forms, structured notes, and a dermatology EMR workflow reduce the missing documentation that causes claim denials.

Book a demo

CPT and HCPCS codes commonly paired with L80

L80 is the diagnosis code; the CPT and HCPCS codes below are the procedure codes billed alongside it. Coverage for vitiligo treatment varies significantly by payer, and specific code pairings should be verified against current AMA CPT guidelines and individual payer medical policies. The ICD List code reference provides a cross-reference tool to check which procedure codes are paired with L80 across payer systems. Practices managing these claim submissions can use Pabau’s claims management software to organize procedure-diagnosis pairings before submission.

Insurance coverage for vitiligo treatment varies by payer and plan. Many commercial payers consider narrowband UVB phototherapy medically necessary for extensive vitiligo when prior treatment has failed, but prior authorization is typically required. Excimer laser claims often face stricter documentation requirements. Do not assume coverage based on diagnosis alone; always verify individual payer medical policies before scheduling phototherapy.

How Pabau supports vitiligo coding and clinical documentation

Dermatology and skin care practice teams face a documentation challenge unique to vitiligo: the condition requires serial photographic evidence, precise body surface area estimates, and explicit autoimmune history capture to support both the diagnosis code and the treatment procedure codes billed alongside it.

Pabau’s dermatology EMR software supports structured clinical notes that capture the specific language payers look for in L80 claims. Providers can document vitiligo pattern type, affected body regions, and treatment response within a single structured encounter note, reducing the risk of under-documentation at billing time.

• Structured digital forms: pre-built skin condition intake forms capture the diagnosis history, distribution, and comorbid autoimmune conditions that support L80 coding from the first visit
• Before-and-after photo tools: serial documentation of depigmented patches at each visit builds the treatment response record that phototherapy claims require
• Client records: Pabau’s client records maintain a longitudinal view of vitiligo progression across visits, helping coders and clinicians track disease extent for ongoing treatment authorization
• Claims workflow: diagnosis code entry at the encounter level feeds directly into the billing workflow, connecting clinical documentation directly to claim submission

For practices managing multiple skin conditions across a patient base, Pabau’s skin clinic software brings dermatology documentation workflows, appointment scheduling, and billing into one system, reducing the data entry duplication that generates coding errors.

Pabau’s clinical notes include built-in ICD-10 code search, so providers can find and attach the correct diagnosis code, including L80, without leaving the note or switching to a separate lookup tool.

Conclusion

Vitiligo is one of the cleaner ICD-10 coding scenarios in dermatology: one specific, stable, billable code with no Excludes1 complications. The real risk is in the documentation layer, not the code selection itself. Practices that capture explicit vitiligo language, body distribution data, and treatment response notes at every encounter will find L80 claims move cleanly through adjudication.

Pabau’s structured clinical notes, before-and-after photo tools, and dermatology-focused workflows are built to prevent the documentation shortfalls that turn clean L80 diagnoses into denied claims. See how a skin care practice put this into practice in the Bea Esthetics case study.

Continue your research

Coding a complex facial repair alongside a skin diagnosis? CPT Code 13153 covers the add-on for complex repairs of the eyelids, nose, ears, and lips that often accompany dermatologic procedures.

Billing an intermediate wound repair on the same visit? CPT Code 12047 breaks down the billing rules for intermediate repairs, a common pairing with dermatology diagnosis codes.

Coding a nail bed procedure during the same encounter? CPT Code 11760 explains the reimbursement and documentation rules for nail bed repair, another integumentary procedure coders handle alongside skin diagnoses.

Frequently asked questions